Look for:

Our offer for

TERUMO CORP


ISIN:
JP3546800008
WKN:
4543

2024/11/01 08:13:38
Price
17.10 EUR
Difference -2.29% (-0.40)

General attributes

ISINJP3546800008
Symbol4543
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)25,918 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)17.30 EUR (200)
Ask (Ask size)17.70 EUR (200)
Open17.10 EUR
High17.10 EUR
Low17.10 EUR
Close (prev. day)17.50 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: TERUMO CORPPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/11/01 08:13:38
Price
17.10 EUR
Difference -2.29% (-0.40)

General attributes

ISINJP3546800008
Symbol4543
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)25,918 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)17.30 EUR (200)
Ask (Ask size)17.70 EUR (200)
Open17.10 EUR
High17.10 EUR
Low17.10 EUR
Close (prev. day)17.50 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6M1Y3Y
Perf (%)+9.38%+36.72%-7.10%
Perf (abs.)+1.50+4.70-1.34
Beta1.031.021.00
Volatility39.4533.9129.88
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)17.54 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)17.34 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)16.36 EUR (2)
Ø price 250 days | Ø volume 250 days (pcs.)15.98 EUR (1)
YTD High | date18.10 EUR (2024/03/05)
YTD Low | date13.40 EUR (2024/08/05)
52 Weeks High | date18.10 EUR (2024/03/05)
52 Weeks Low | date12.90 EUR (2023/11/01)

All listings for TERUMO CORP

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/10/3122:2617.50 EUR0.001
Tokyo Stock Exchange2024/11/0107:002,886.50 JPY113.697,425
Stuttgart2024/11/0108:1317.10 EUR0.001
Munich2024/11/0108:0317.50 EUR0.001
Hanover2024/11/0108:0117.10 EUR0.001
Frankfurt2024/11/0108:1017.10 EUR0.001
FINRA other OTC Issues2024/10/3116:0518.384 USD0.0313
Duesseldorf2024/11/0112:3017.20 EUR0.003
Berlin2024/11/0108:0317.10 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=7574&ID_TYPE_IMAGE_LOGO=2

Contact Details

TERUMO CORP.
- -
2-44-1 Hatagaya, Shibuya-Ku - 151-0072 Tokyo
Telefon: +81-3-3374-8111
Fax: +
E-mail: kouhou_terumo01@terumo.co.jp

PDF Downloads

Annual report: TERUMO CORPPDF Download

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.

Members of Management Board

Shinjiro SatoChairman of Managing Board
Antoinette GawinMember of Executive Committee
Fumihisa HiroseMember of Executive Committee
Hiraku SamejimaMember of Executive Committee
Kazunori HiroseMember of Executive Committee
Norimasa KunimotoMember of Executive Committee
Shoji HatanoMember of Executive Committee
Toshiaki TakagiMember of Executive Committee
Toshihiko OsadaMember of Executive Committee

Board of directors

Toshiaki TakagiChairman of Supervisory Board
Hidenori NishiMember of Supervisory Board
Keiya OzawaMember of Supervisory Board
Kyo NishikawaMember of Supervisory Board
Masaichi NakamuraMember of Supervisory Board
Shinjiro SatoMember of Supervisory Board
Shouji HatanoMember of Supervisory Board
Soichiro UnoMember of Supervisory Board
Takanori ShibazakiMember of Supervisory Board
Yukiko KurodaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.